Bio-Rad Laboratories, Inc. Class ABio-Rad Laboratories, Inc. Class ABio-Rad Laboratories, Inc. Class A

Bio-Rad Laboratories, Inc. Class A

No trades
See on Supercharts

Price target

284.180.000.00%
The 6 analysts offering 1 year price forecasts for BUWA have a max estimate of — and a min estimate of —.

Analyst rating

Based on 9 analysts giving stock ratings to BUWA in the past 3 months.

EPS

Reported
Estimate
Reported
Estimate
Surprise

Revenue

Reported
Estimate
Reported
Estimate
Surprise
Be warned

Frequently Asked Questions


BUWA EPS for the last quarter is 2.22 EUR despite the estimation of 1.47 EUR. In the next quarter EPS is expected to reach 1.68 EUR. Track more of Bio-Rad Laboratories, Inc. Class A financials and stay on top of what is up with the company.
In the next quarter Bio-Rad Laboratories, Inc. Class A revenue is expected to reach ‪560.66 M‬ EUR. Check out Bio-Rad Laboratories, Inc. Class A revenue and earnings and make informed decisions.
According to analysts, BUWA price target is 284.18 EUR with a max estimate of 374.06 EUR and a min estimate of 226.83 EUR. Check if this forecast comes true in a year, meanwhile watch Bio-Rad Laboratories, Inc. Class A stock price chart and keep track of the current situation with BUWA news and stock market news.
We've gathered opinions of 9 analysts rating BUWA stock in the past 3 months. Most of them backed up the strong buy trend, and after taking into account other opinions, the overall rating was calculated as buy. Note that it's not a trading advice — your own analysis is still required.